Disease Prognostication

Disease Prognostication is a clinical assessment framework that, as a genus, belongs to the class of diagnostic reasoning methods, and, by differentia, specifically entails the prediction of the likely course, outcomes, and complications of cardiac amyloidosis based on imaging-derived biomarkers and patient-specific disease characteristics.

644

Publications

42.2K

Citations

4.8K

Authors

1.4K

Institutions

Publications per year

2017–2026

356

Variants

Prognostication

Authors

4.8K

  1. AD
    Angela Dispenzieri

    Mayo Clinic, United States

    27 publications · 3.3K citations

    21

    h-index

  2. PN
    Philip N. Hawkins

    University College London, United Kingdom

    24 publications · 3.9K citations

    19

    h-index

  3. MA
    Morie A. Gertz

    Mayo Clinic, United States

    23 publications · 3.4K citations

    19

    h-index

  4. JD
    Julian D. Gillmore

    University College London, United Kingdom

    26 publications · 3.4K citations

    19

    h-index

  5. AW
    Ashutosh Wechalekar

    University College London, United Kingdom

    23 publications · 3.2K citations

    19

    h-index

1–5 of 4.8K

Venues

  1. PubMed

    Repository · 23 publications · 992 citations

    16

    h-index

  2. Amyloid

    18 publications · 686 citations

    15

    h-index

  3. PLoS ONE

    13 publications · 445 citations

    12

    h-index

  4. The American Journal of Cardiology

    11 publications · 557 citations

    11

    h-index

  5. European Journal of Heart Failure

    11 publications · 1.1K citations

    11

    h-index

1–5